Cargando…
Angiogenetic Factors in Chronic Subdural Hematoma Development
The levels of angiogenic factors were analyzed in eight patients who underwent the embolization of chronic subdural hematoma (CSDH) with non-adhesive liquid embolic agents. Four of these patients had previously undergone surgical treatment for hematoma removal and had recurrences of a similar volume...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689028/ https://www.ncbi.nlm.nih.gov/pubmed/36428849 http://dx.doi.org/10.3390/diagnostics12112787 |
_version_ | 1784836420447240192 |
---|---|
author | Petrov, Andrey Ivanov, Arkady Dryagina, Natalia Petrova, Anna Samochernykh, Konstantin Rozhchenko, Larisa |
author_facet | Petrov, Andrey Ivanov, Arkady Dryagina, Natalia Petrova, Anna Samochernykh, Konstantin Rozhchenko, Larisa |
author_sort | Petrov, Andrey |
collection | PubMed |
description | The levels of angiogenic factors were analyzed in eight patients who underwent the embolization of chronic subdural hematoma (CSDH) with non-adhesive liquid embolic agents. Four of these patients had previously undergone surgical treatment for hematoma removal and had recurrences of a similar volume, and four had an increase in hematoma volume due to rebleeding. The levels of vascular endothelial growth factor (VEGF), matrix metallopeptidase 9 (MMP 9), angiopoietin-2 (Ang2), transforming growth factor beta 1 (TGF-β1) and platelet-derived growth factor BB (PDGF-BB) in the arterial and venous blood were analyzed. The most significant results were obtained from the peripheral venous blood samples. The levels of VEGF in the samples of all the patients were close to normal or slightly decreased. There was an increase in the MMP9 levels (the factor that contributes to the disintegration of the vessel wall components) in all the patients. The Ang2 and especially the PDGF TGF-β1 (the factor that plays an important role in the growth of the vessel wall from the already existing blood vessel tissue) levels were distinctly low in most of the cases and slightly elevated only in a number of patients who had previously been operated on. The results obtained show that there is an imbalance in the angiogenesis factors in patients with rebleeding CSDH. At the same time, the factors determining the formation of the vessel wall were reduced, and the levels of factors contributing to the degradation of extracellular matrix components were significantly increased. Such factors could help us to anticipate the increased risk of hemorrhages. Highlights: The levels of VEGF, MMP 9, Ang2, TGF-β1 and PDGF-BB in the arterial and venous blood were analyzed. The most significant results were obtained from the peripheral venous blood samples. The results obtained show that there is an imbalance in the angiogenesis factors in patients with rebleeding CSDH. Such a profile of factors could help us to anticipate the increased risk of hemorrhages. |
format | Online Article Text |
id | pubmed-9689028 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96890282022-11-25 Angiogenetic Factors in Chronic Subdural Hematoma Development Petrov, Andrey Ivanov, Arkady Dryagina, Natalia Petrova, Anna Samochernykh, Konstantin Rozhchenko, Larisa Diagnostics (Basel) Case Report The levels of angiogenic factors were analyzed in eight patients who underwent the embolization of chronic subdural hematoma (CSDH) with non-adhesive liquid embolic agents. Four of these patients had previously undergone surgical treatment for hematoma removal and had recurrences of a similar volume, and four had an increase in hematoma volume due to rebleeding. The levels of vascular endothelial growth factor (VEGF), matrix metallopeptidase 9 (MMP 9), angiopoietin-2 (Ang2), transforming growth factor beta 1 (TGF-β1) and platelet-derived growth factor BB (PDGF-BB) in the arterial and venous blood were analyzed. The most significant results were obtained from the peripheral venous blood samples. The levels of VEGF in the samples of all the patients were close to normal or slightly decreased. There was an increase in the MMP9 levels (the factor that contributes to the disintegration of the vessel wall components) in all the patients. The Ang2 and especially the PDGF TGF-β1 (the factor that plays an important role in the growth of the vessel wall from the already existing blood vessel tissue) levels were distinctly low in most of the cases and slightly elevated only in a number of patients who had previously been operated on. The results obtained show that there is an imbalance in the angiogenesis factors in patients with rebleeding CSDH. At the same time, the factors determining the formation of the vessel wall were reduced, and the levels of factors contributing to the degradation of extracellular matrix components were significantly increased. Such factors could help us to anticipate the increased risk of hemorrhages. Highlights: The levels of VEGF, MMP 9, Ang2, TGF-β1 and PDGF-BB in the arterial and venous blood were analyzed. The most significant results were obtained from the peripheral venous blood samples. The results obtained show that there is an imbalance in the angiogenesis factors in patients with rebleeding CSDH. Such a profile of factors could help us to anticipate the increased risk of hemorrhages. MDPI 2022-11-14 /pmc/articles/PMC9689028/ /pubmed/36428849 http://dx.doi.org/10.3390/diagnostics12112787 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Petrov, Andrey Ivanov, Arkady Dryagina, Natalia Petrova, Anna Samochernykh, Konstantin Rozhchenko, Larisa Angiogenetic Factors in Chronic Subdural Hematoma Development |
title | Angiogenetic Factors in Chronic Subdural Hematoma Development |
title_full | Angiogenetic Factors in Chronic Subdural Hematoma Development |
title_fullStr | Angiogenetic Factors in Chronic Subdural Hematoma Development |
title_full_unstemmed | Angiogenetic Factors in Chronic Subdural Hematoma Development |
title_short | Angiogenetic Factors in Chronic Subdural Hematoma Development |
title_sort | angiogenetic factors in chronic subdural hematoma development |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689028/ https://www.ncbi.nlm.nih.gov/pubmed/36428849 http://dx.doi.org/10.3390/diagnostics12112787 |
work_keys_str_mv | AT petrovandrey angiogeneticfactorsinchronicsubduralhematomadevelopment AT ivanovarkady angiogeneticfactorsinchronicsubduralhematomadevelopment AT dryaginanatalia angiogeneticfactorsinchronicsubduralhematomadevelopment AT petrovaanna angiogeneticfactorsinchronicsubduralhematomadevelopment AT samochernykhkonstantin angiogeneticfactorsinchronicsubduralhematomadevelopment AT rozhchenkolarisa angiogeneticfactorsinchronicsubduralhematomadevelopment |